Log in

Relevant bibliographies by topics / Treatment of hepatitis C

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Treatment of hepatitis C'

Author: Grafiati

Published: 4 June 2021

Last updated: 12 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Treatment of hepatitis C.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Treatment of hepatitis C"

1

Mayhew, Maren S. "Hepatitis C Treatment." Journal for Nurse Practitioners 7, no. 10 (2011): 875–76. http://dx.doi.org/10.1016/j.nurpra.2011.09.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Downey, Nancy H. "Hepatitis C Treatment." Gastroenterology Nursing 31, no. 2 (2008): 162. http://dx.doi.org/10.1097/01.sga.0000316567.85555.71.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Full text

Abstract:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

APA, Harvard, Vancouver, ISO, and other styles

4

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Full text

Abstract:

INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa

APA, Harvard, Vancouver, ISO, and other styles

5

Shirokova, Irina, and Nadezhda Kalinina. "Hepatitis C treatment breakthroughs." Remedium Journal about the Russian market of medicines and medical equipment, no. 7-8 (2020): 19–22. http://dx.doi.org/10.21518/1561-5936-2020-7-8-19-22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Satoor, Sumalatha, and Jean-Pierre Raufman. "Treatment of hepatitis C." Clinical Cornerstone 3, no. 6 (2001): 37–46. http://dx.doi.org/10.1016/s1098-3597(01)90077-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hunt, Summer. "New Hepatitis C Treatment." Nursing for Women's Health 21, no. 5 (2017): 335. http://dx.doi.org/10.1016/s1751-4851(17)30255-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lerias de Almeida, Paulo Roberto. "Acute hepatitis C treatment." Annals of Hepatology 9 (2010): S107—S111. http://dx.doi.org/10.1016/s1665-2681(19)31734-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schwetz, B. A. "Treatment for Hepatitis C." JAMA: The Journal of the American Medical Association 286, no. 10 (2001): 1166—a—1166. http://dx.doi.org/10.1001/jama.286.10.1166-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Schwetz, Bernard A. "Treatment for Hepatitis C." JAMA 286, no. 10 (2001): 1166. http://dx.doi.org/10.1001/jama.286.10.1166-jfd10008-2-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Treatment of hepatitis C"

1

Carlsson, Tony. "Hepatitis C virus kinetics during antiviral treatment /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-588-3/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Yuen, King-tai, and 袁敬弟. "A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193555.

Full text

Abstract:

The cost effectiveness of using novel HCV treatment option, telaprevir and boceprevir, should depend on patients’ respond to conventional PEG-INFα and ribavirin therapy. The study of pharmacogenomics, interleukin-28B (IL-28B) polymorphisms, accompanied with the information of HCV genotypes are suggested to have the strongest predictive value of treatment outcomes and prognosis of disease in individuals infected with HCV who are undergoing conventional PEG-INFα and ribavirin therapy. It is extremely valuable in HCV/HIV co-infected patients as these groups of patients require a complex treatment

APA, Harvard, Vancouver, ISO, and other styles

3

Weegink, Christine Joanne. "Hepatitis C infection the quest for new treatment strategies /." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2004. http://dare.uva.nl/document/74129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Christou, Marie-Grace. "Conditionally activated therapeutics for the treatment of hepatitis C." Thesis, University of Ottawa (Canada), 2004. http://hdl.handle.net/10393/26609.

Full text

Abstract:

Hepatitis C virus (HCV) is the etiologic agent responsible for the majority of cases of non-A, non-B hepatitis. It is estimated that 2% of the world's population is infected with hepatitis C with roughly 75% of infections progressing into a chronic state. Current interferon therapy is largely ineffective against chronic Hepatitis C due to the induction of interferon-resistance by HCV. The underlying mechanisms for resistance to interferon therapy have been widely studied and documented and as is the case in interferon resistant malignancies, there is some evidence that HCV infected cells are m

APA, Harvard, Vancouver, ISO, and other styles

5

Smith, Jennifer. "Viral diversity and dynamics of hepatitis C virus." Thesis, University of Oxford, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559853.

Full text

Abstract:

Complex patterns of HCV infection are increasingly reported, particularly in highly exposed individuals, with multiple and variable subtype profiles seen in many chronic patients. This study aims to address some of the questions arising from this increasingly diverse and dynamic picture, both within hosts and at a population level. In Chapter 2 I find evidence for a highly dynamic infection profile in acute HCV, both in terms of viral load and the dominant subtype. I extrapolate these observations from individual patients to formulate a model of HCV transmission across a high-risk population i

APA, Harvard, Vancouver, ISO, and other styles

6

Veldt, Bartholomeus Johannes. "Long-term clinical outcome of treatment for chronic hepatitis C." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2008. http://hdl.handle.net/1765/12624.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Whiteley, David James. "Recontextualising the lived experience of hepatitis C and its treatment." Thesis, Edinburgh Napier University, 2016. http://researchrepository.napier.ac.uk/Output/979740.

Full text

Abstract:

BACKGROUND: Rapid advances in the treatment of the hepatitis C virus (HCV) have been witnessed in clinical practice over the last five years. Pharmacological developments have ended the reliance on the drug interferon-α as a component of successful therapy, heralding the dawn of a new era in the fight against the disease. How this new era is being understood and experienced by those individuals living with the virus is currently unknown. METHODS: A purposive sample of 20 individuals participated in face-to-face semi-structured interviews exploring their experience of living with HCV. Eight of

APA, Harvard, Vancouver, ISO, and other styles

8

Sgorbini, Myra. "Living with Hepatitis C and treatment a phenomenological study of the experience of patients and their partners /." View thesis, 2007. http://handle.uws.edu.au:8081/1959.7/19046.

Full text

Abstract:

Thesis (M.Sc. (Hons.)) -- University of Western Sydney, 2007.<br>A thesis submitted towards the degree of Master of Nursing (Honours) in the University of Western Sydney, College of Health and Science, School of Nursing. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

9

Laestadius, Hanna, and Berfin Güven. "Hur patienter med hepatit B och hepatit C upplever bemötandet av omvårdnadspersonal." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-397661.

Full text

Abstract:

Background: In 2019, hepatitis is seen as one of the deadliest virus infections in the world and is seen as a global health problem. Hepatitis is a DNA-virus that can lead to chronic hepatitis and liver cirrhosis. Both hepatitis B and C are blood infections which means that they are transmitted through contact with damaged skin, mucus membrane or the eyes. Aim: The aim of this study was to describe how patients with hepatitis B and C experience the treatment from healthcare professionals. Method: The method used in this study was a review of literature research. The study was conducted through

APA, Harvard, Vancouver, ISO, and other styles

10

Cornacini, Milena Costa Menezes [UNESP]. "Efeito do uso do cogumelo Agaricus brasiliensis no estado nutricional, na frequência e intensidade dos efeitos adversos da terapia medicamentosa e na resposta bioquímica hepática em indivíduos com hepatite crônica pelo vírus C: estudo prospectivo, randomizado, duplo cego, placebo controlado." Universidade Estadual Paulista (UNESP), 2009. http://hdl.handle.net/11449/102636.

Full text

Abstract:

Made available in DSpace on 2014-06-11T19:32:12Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-07-23Bitstream added on 2014-06-13T18:43:14Z : No. of bitstreams: 1 cornacini_mcm_dr_botfm.pdf: 480494 bytes, checksum: b0bc2df21341fdbd2b117efc1905a4b8 (MD5)<br>Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)<br>Diversos estudos, indicam que o cogumelo Agaricus brasiliensis é benéfico em várias condições clínicas, como na hepatite C. Várias espécies de cogumelos comestíveis têm sido exploradas quanto ao seu potencial medicinal e muitos pacientes passam a buscar a soluç

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Treatment of hepatitis C"

1

Chayama, Kazuaki, ed. Hepatitis C Virus Treatment. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2416-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hatzakis, Angelos, ed. Hepatitis C: Care and Treatment. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67762-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hepatitis C. Oxford University Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hepatitis C infection: Management and treatment. Martin Dunitz, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Porter, Lucinda K. Free from hepatitis C: Your complete guide to healing hepatitis C. Square One Publishers, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. T. Duncan, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Colbert, Don. The Bible cure for hepatitis and hepatitis C. Siloam Press, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Texas. Dept. of Health. Hepatitis C action plan for Texas. Texas Dept. of Health, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ravalec, Vincent. Hépatite C: Récit. Flammarion, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hépatite C: Récit. Flammarion, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Treatment of hepatitis C"

1

Welsch, Christoph, and Stefan Zeuzem. "Treatment of Hepatitis C." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cannon, Mary D., Kosh Agarwal, and Geoffrey Dusheiko. "Hepatitis C: Treatment." In Evidence-based Gastroenterology and Hepatology 4e. John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781119211419.ch31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Damen, M., and D. Bresters. "Hepatitis C Treatment." In Current Studies in Hematology and Blood Transfusion. KARGER, 1998. http://dx.doi.org/10.1159/000060479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Karino, Yoshiyasu. "Treatment of Chronic Hepatitis C with the First-Generation Protease Inhibitor Telaprevir: Its Efficacy and Resistance Mutations." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Takehara, Tetsuo. "Features of the Second Wave of the First Generation Protease Inhibitors: Effect and Tolerance." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mitsui, Fukiko, C. Nelson Hayes, Fumitaka Suzuki, and Kazuaki Chayama. "The Efficacy of Daclatasvir Plus Asunaprevir Combination Therapy with Chronic Hepatitis." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mochida, Satoshi. "Resistance-Associated Variants in the NS5A Region of HCV and Methods for the Detection." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Maekawa, Shinya, Mitsuaki Sato, and Nobuyuki Enomoto. "Detection of Antiviral Drug-Resistant Variants in Chronic Hepatitis C by Deep Sequencing." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Suda, Goki, Jun Ito, Kenichi Morikawa, Koji Ogawa, and Naoya Sakamoto. "Incidence and Characteristics of Naturally Occurring Drug-Resistant Hepatitis C Virus Strains." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hayes, C. Nelson, Masaaki Korenaga, and Masashi Mizokami. "Treatment Effects and Resistance-Associated Variants of Sofosbuvir Regimen for Japanese Patients with Chronic Hepatitis C Virus Genotypes 1 and 2." In Hepatitis C Virus Treatment. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2416-0_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Treatment of hepatitis C"

1

Brito, A., A. Fernandes, L. Lourenço, S. Domingos, A. Soares, and A. Alcobia. "1ISG-006 Hepatitis C treatment: cost and effectiveness." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cabo, Domingos Jose Vaz Do, Silvia Helena Grosso Esher, Maria Filomena Xavier Mendes, Romeu Carillo Jr, and Maria Solange Gosik. "Developing Homeopathic Treatment Guidelines for Patients with Hepatitis C." In HRI London 2019—Cutting Edge Research in Homeopathy: Presentation Abstracts. The Faculty of Homeopathy, 2020. http://dx.doi.org/10.1055/s-0040-1702136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Schwambach, Karin Hepp, and Carine Raquel Blatt. "Effectiveness and costs: real-world data to Hepatitis C treatment." In PRIMEIRO CONGRESSO DA REBRATS. Galoa, 2019. http://dx.doi.org/10.17648/rebrats-2019-113738.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Coghlan, M., A. O’Leary, G. Melanophy, S. Norris, and C. Bergin. "NP-018 Building capacity within a Hepatitis C treatment model. The validation process for a Hepatitis C pre-treatment pharmacist assessment complex intervention toolkit." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Huang, Hao, Zelda B. Zabinsky, Yuankun Li, and Shan Liu. "Analyzing hepatitis C screening and treatment strategies using Probabilistic Branch and Bound." In 2016 Winter Simulation Conference (WSC). IEEE, 2016. http://dx.doi.org/10.1109/wsc.2016.7822251.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Eissa, Mohammed M., Mohammed Elmogy, Mohammed Hashem, and Farid A. Badria. "Hybrid Rough Genetic algorithm model for making treatment decisions of hepatitis C." In 2014 International Conference on Engineering and Technology (ICET). IEEE, 2014. http://dx.doi.org/10.1109/icengtechnol.2014.7016784.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Schmidt, FP, T. Wenz, B. Schnorbus, et al. "Treatment with direct-acting antivirals for Hepatitis C infection improves vascular function." In Viszeralmedizin 2017. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1605028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Corrigall, Douglas, Linda Porter, Sarah Fairclough, Katrina White, Denise Killworth, and Gavin Wright. "PTH-087 Improving hepatitis C detection and treatment via community-based services." In British Society of Gastroenterology, Annual General Meeting, 4–7 June 2018, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-bsgabstracts.243.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Badria, Farid A., Mohammed M. Eissa, Mohammed Elmogy, and Mohammed Hashem. "Rough Based Granular Computing Approach for Making Treatment Decisions of Hepatitis C." In 2013 23rd International Conference on Computer Theory and Applications (ICCTA). IEEE, 2013. http://dx.doi.org/10.1109/iccta32607.2013.9529777.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Eissa, Mohammed M., Mohammed Elmogy, and Mohammed Hashem. "Rough — Granular neural network model for making treatment decisions of Hepatitis C." In 2014 9th International Conference on Informatics and Systems (INFOS). IEEE, 2014. http://dx.doi.org/10.1109/infos.2014.7036703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Treatment of hepatitis C"

1

Kuypers, Marshall A., Gregory Joseph Lambert, Thomas W. Moore, et al. Modeling Hepatitis C treatment policy. Office of Scientific and Technical Information (OSTI), 2013. http://dx.doi.org/10.2172/1096266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Holtzmuller, Kent. Utilization of Telemedicine for Evaluation and Treatment of Hepatitis C Patients in Military Health Clinics. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada396498.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Holtzmuller, Kent. Utilization of Telemedicine for Evaluation and Treatment of Hepatitis C Patients in Military Health Clinics. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Evon, Donna, Jipcy Amador, Paul Stewart, et al. Changes in Health for Patients Who Complete Treatment for Chronic Hepatitis C Virus -- The PROP up TARGET Study. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/06.2020.cer.140820660.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mark, Tami L., William N. Dowd, and Carol L. Council. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality. RTI Press, 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0040.2007.

Full text

Abstract:

The objective of this study was to track trends in the signs of higher-quality addiction treatment as defined by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Addiction, and the Substance Abuse and Mental Health Services Administration. We analyzed the National Survey of Substance Abuse Treatment Services from 2007 through 2017 to determine the percent of facilities having the characteristics of higher quality. We analyzed the percent by state and over time. • We found improvements between 2007 and 2017 on most measures, but performance on several measures r

APA, Harvard, Vancouver, ISO, and other styles

6

Sjogren, Maria H., and Kent Holtzmuller. Hepatitis C Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada406083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sjogren, Maria H. Hepatitis C. Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada433067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sjogren, Maria H., and Brooke Huntley. Hepatitis C. Virus Infection: Mechanisms of Disease Progression. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada477987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Koizumi, Yoshiki, Syo Nakajim, Hirofumi Ohash, et al. Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection. Office of Scientific and Technical Information (OSTI), 2016. http://dx.doi.org/10.2172/1242919.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Nguyen, Tung, Mandana Khalili, Janice Tsoh, et al. Comparing Ways to Increase Hepatitis B and C Screening Among Asian Americans. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/02.2020.ad.12114615.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!